The Eaton Vance Enhanced Equity Income Fund II (EOS) remains a buy, providing an attractive 8.3% yield and trading at a deep 8.96% discount to its net asset value. Its option-writing strategy limits upside potential but delivers consistent, tax-efficient monthly income, making it suitable for retirees prioritizing stability over growth. Despite competition from lower-fee ETFs, EOS's net realized gains and NAV growth support sustainable payouts. However, its heavy tech sector exposure and capped growth mean it could be vulnerable to sector downturns, though its payout coverage and tax advantages remain strong positives.
Confo Therapeutics announced encouraging preclinical data for CFTX-2034, a novel antibody targeting post-bariatric hypoglycemia (PBH), a condition with no approved treatments. The data showed CFTX-2034 effectively controls insulin and GLP-1 secretion...
Pardee Resources Company announced an agreement to sell about 2,465 acres of surface and mineral property in West Virginia for approximately $57 million, priced at $23,000 per acre. The sale depends on certain contingencies and normal closing conditi...
Western Digital's stock surged to a new 52-week high following a bullish upgrade by Morgan Stanley analyst Erik Woodring, who raised his price target from $488 to $650. The optimism is driven by expected 30%+ year-over-year growth in nearline enterpr...
Nuvei announced it will acquire Payoneer in an all-cash deal valued at $2.75 billion, offering Payoneer shareholders $7.40 per share. The merger aims to create a global commerce platform supporting businesses in over 190 countries, enhancing payment ...
Eli Lilly announced that its Phase 3 BRUIN CLL-322 trial showed adding Jaypirca (pirtobrutinib) to venetoclax and rituximab significantly improved progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or...
